Head lice treatment study comparing a new product to Nix
Part of Infections, Skin clinical trials.
This trial tests a new head lice product (X92001483) to see how safe and effective it is compared to the standard treatment Nix. It looks at both getting rid of lice and preventing them from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 1 year old.
- You or your caregiver must agree to the study and sign consent forms.
- You must have at least 5 live lice and 5 live nits (eggs) on your scalp or hair.
- You cannot use any other lice treatments or medicated hair products during the study.
- You must agree not to wash or rinse your hair for 24 hours after treatment.
- All members of your household must be checked for lice and be willing to join the study if they have them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medical device for head lice compared to a standard anti-lice shampoo. It aims to see if the device is safe and works well for people with mild to moderate lice.
This study compares a new lice lotion to a standard lice shampoo to see how well they work and if they are safe. If you or your child has head lice, participating could help find a better way to get rid of them.
This study tests a new shampoo to treat head lice. It is for people with mild to moderate lice and compares the new shampoo to a standard treatment.
This study tests a new medicine (N1087) to see if it helps women with female pattern hair loss. It compares the study drug to a placebo (a dummy product) to check how well it works and if it's safe.
This study tests a new antidandruff lotion designed to restore the natural balance of microbes on your scalp. If you have moderate to severe dandruff and are generally healthy, this trial may help improve your dandruff with a specially formulated product.
This study tests a new experimental drug called PG-033 in healthy adults. It helps doctors find out if the drug is safe and how your body processes it at different dose levels.
Hear when a new Lice; Head Lice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.